Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 25, 2021

The impact of glutaraldehyde on the characteristics of bovine hydroxyapatite-gelatin based bone scaffold as gentamicin delivery system

  • Aniek Setiya Budiatin , Maria Apriliani Gani , Chrismawan Ardianto , Samirah , Sahrati Yudiaprijah Daeng Pattah , Fitroh Mubarokah and Junaidi Khotib

Abstract

Objectives

Biomaterials are widely used as drug delivery systems targeting bone tissue, such as to treat bone infectious disease. However, the addition of drugs to biomaterials weakens their mechanical properties. Crosslinkers are compounds that improve the mechanical properties of biomaterials. This study aims to determine the effect of glutaraldehyde (GTA) as a crosslinker on the characteristics of bovine hydroxyapatite-gelatin-based bone scaffold with gentamicin as antibiotics (BHA-GEL-GEN-GTA).

Methods

BHA-GEL-GEN-GTA scaffold with GTA solid content ranging from 0.1 to 1.4 wt% was made by direct compression. The compressive strength test was carried out using autograph. Scaffold degradation test was carried out by dissolving the scaffolds in PBS. Scaffold toxicity was performed by MTT assay using BHK-21 fibroblast cells.

Results

There was a significant difference in the scaffolds’ compressive strength due to differences in GTA volume. Scaffold crosslinked using GTA with solid content 0.1 and 0.2 wt% in 2 mL solution had higher compressive strength than those in 1 mL solution. Furthermore, GTA with solid content 0.6, 1, 1.2, and 1.4 wt% showed higher compressive strength than those without GTA. Degradation test results showed that GTA increased the percentage of weight loss and swelling of the scaffold. The scaffold exhibited a nontoxic profile in MTT assay.

Conclusions

GTA with optimum solid content shows great compressive strength, stable swelling profile with low percentage of scaffold’s weight loss, and is considered as nontoxic.


Corresponding author: Aniek Setiya Budiatin, Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia, Phone: +62 818 597 732, E-mail:

Funding source: Ministry of Research and Technology of the Republic of Indonesia

Award Identifier / Grant number: 007/F1/PPK.2/Kp/V/2019

Acknowledgments

The author thanks the Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University for all support during research.

  1. Research funding: This work was supported by the Ministry of Research and Technology of the Republic of Indonesia, through strengthening industrial innovation research scheme fiscal year 2019 [grant number: 007/F1/PPK.2/Kp/V/2019].

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Javaid, MA, Kaartinen, MT. Mesenchymal stem cell-based bone tissue engineering. Int Dent J Student Res 2013;1:24–35.Search in Google Scholar

2. Chang, Y, Tai, CL, Hsieh, PH, Ueng, SW. Gentamicin in bone cement: a potentially more effective prophylactic measure of infection in joint arthroplasty. Bone Joint Res 2013;2:220–6. https://doi.org/10.1302/2046-3758.210.2000188.Search in Google Scholar

3. Budiatin, AS, Zainuddin, M, Khotib, J. Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration. Int J Pharm Pharmaceut Sci 2014;6:223–6.Search in Google Scholar

4. Budiatin, AS, Samirah Gani, MA, Nilamsari, WP, Ardianto, C, Khotib, J. The characterization of bovine bone-derived hydroxyapatite isolated using novel non-hazardous method. J Biomim Biomater Biomed Eng 2020;45:49–56. https://doi.org/10.4028/www.scientific.net/jbbbe.45.49.Search in Google Scholar

5. Germaini, MM, Detsch, R, Grünewald, A, Magnaudeix, A, Lalloue, F, Boccaccini, AR, et al.. Osteoblast and osteoclast responses to A/B type carbonate-substituted hydroxyapatite ceramics for bone regeneration. Biomed Mater 2017;12:035008. https://doi.org/10.1088/1748-605x/aa69c3.Search in Google Scholar

6. Chang, MC, Ko, CC, Douglas, WH. Preparation of hydroxyapatite-gelatin nanocomposite. Biomaterials 2003;24:2853–62. https://doi.org/10.1016/s0142-9612(03)00115-7.Search in Google Scholar

7. Hu, H, Huang, BW, Lee, YT, Hu, J, Wong, SW, Ko, CC, et al.. Dramatic improvement of the mechanical strength of silane-modified hydroxyapatite-gelatin composites via processing with cosolvent. ACS Omega 2018;3:3592–8. https://doi.org/10.1021/acsomega.7b01924.Search in Google Scholar PubMed PubMed Central

8. Zhang, H, Zhou, L, Zhang, W. Control of scaffold degradation in tissue engineering: a review. Tissue Eng B Rev 2014;20:492–502. https://doi.org/10.1089/ten.teb.2013.0452.Search in Google Scholar

9. Oryan, A, Kamali, A, Moshiri, A, Baharvand, H, Daemi, H. Chemical crosslinking of biopolymeric scaffolds: current knowledge and future directions of crosslinked engineered bone scaffolds. Int J Biol Macromol 2018;107:678–88. https://doi.org/10.1016/j.ijbiomac.2017.08.184.Search in Google Scholar PubMed

10. Ebnesajjad, S. Handbook of biopolymers and biodegradable plastics – properties, processing and applications. Netherlands: Elsevier; 2013.Search in Google Scholar

11. Putra, AP, Rahmah, AA, Fitriana, N, Rohim, SA, Jannah, M, Hikmawati, D. The effect of glutaraldehyde on hydroxyapatite-gelatin composite with addition of alendronate for bone filler application. J Biomim Biomater Biomed Eng 2018;37:107–16. https://doi.org/10.4028/www.scientific.net/jbbbe.37.107.Search in Google Scholar

12. Felfel, RM, Ahmed, I, Parsons, AJ, Rudd, CD. Bioresorbable composite screws manufactured via forging process: pull-out, shear, flexural and degradation characteristics. J Mech Behav Biomed Mater 2013;18:108–22. https://doi.org/10.1016/j.jmbbm.2012.11.009.Search in Google Scholar PubMed

13. Raval, BP, Suthar, MP, Patel, RK. Potent in vitro anti-tumor activity of Symplocos racemosa against leukemia and cervical cancer. Electron J Biol 2009;5:89–91.Search in Google Scholar

14. Hikmawati, D, Maulida, HN, Putra, AP, Budiatin, AS, Syahrom, A. Synthesis and characterization of nanohydroxyapatite-gelatin composite with streptomycin as antituberculosis injectable bone substitute. Int J Biomater 2019;2019:7179243. https://doi.org/10.1155/2019/7179243.Search in Google Scholar PubMed PubMed Central

15. Pinto, RV, Gomes, PS, Fernandes, MH, Costa, ME, Almeida, MM. Glutaraldehyde-crosslinking chitosan scaffolds reinforced with calcium phosphate spray-dried granules for bone tissue applications. Mater Sci Eng C 2020;109:110557. https://doi.org/10.1016/j.msec.2019.110557.Search in Google Scholar PubMed

16. Kealser, V, Paula, RMD, Nilsen, G, Grunwald, L, Tidwell, TJ. Biocides overview and applications in petroleum microbiology in Trends in Oil and Gas Corrosion Research and Technologies. Netherlands: Elsevier; 2017.10.1016/B978-0-08-101105-8.00023-1Search in Google Scholar

17. Wang, JQ, Jiang, BJ, Guo, WJ, Zhao, YM. Indirect 3D printing technology for the fabrication of customised β-TCP/chitosan scaffold with the shape of rabbit radial head-an in vitro study. J Orthop Surg Res 2019;14:102. https://doi.org/10.1186/s13018-019-1136-7.Search in Google Scholar PubMed PubMed Central

18. Bharatham, H, Masre, SF, Xien, LH, Ahmad, N. Evaluating physical and biological characteristics of glutaraldehyde (GA) cross-linked nano-biocomposite bone scaffold. Sains Malays 2018;47:2557–63. https://doi.org/10.17576/jsm-2018-4710-32.Search in Google Scholar

Received: 2020-11-26
Accepted: 2021-02-03
Published Online: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 20.5.2024 from https://www.degruyter.com/document/doi/10.1515/jbcpp-2020-0405/html
Scroll to top button